Belatacept in Liver Transplant Recipients
Public ClinicalTrials.gov record NCT00555321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Belatacept as First Line Immunosuppression in De Novo Liver Transplant Recipients
Study identification
- NCT ID
- NCT00555321
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Interventions
- Tacrolimus Drug
- Basiliximab Drug
- Belatacept More Intensive (MI) Drug
- Belatacept Less Intensive (LI) Drug
- Mycophenolate Mofetil (MMF) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Feb 28, 2010
- Completion
- May 31, 2011
- Last update posted
- Oct 17, 2012
2008 – 2011
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Usc University Hospital | Los Angeles | California | 90033 | — |
| University Of California San Francisco Medical Center | San Francisco | California | 94143 | — |
| Mayo Clinic Transplant Department | Jacksonville | Florida | 32224 | — |
| Lifelink Healthcare Institute | Tampa | Florida | 33606 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Northwestern University Feinberg School Of Medicine | Chicago | Illinois | 60611 | — |
| Tulane Center For Abdominal Transplant | New Orleans | Louisiana | 70112 | — |
| Henry Ford Hospital | Detriot | Michigan | 48202 | — |
| University Of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| Nyu School Of Medicine | New York | New York | 10016 | — |
| Westchester Medical Center | Valhalla | New York | 10595 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Univ. Of Cin. Coll. Of Med. | Cincinnati | Ohio | 45267 | — |
| Integris-Baptist Medical Ctr. | Oklahoma City | Oklahoma | 73112 | — |
| Hospital Of The University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Froedtert Memorial Lutheran Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00555321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00555321 live on ClinicalTrials.gov.